Cure Today43m
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.
Biodexa Pharmaceuticals ADRs Rise After Cancer Drug Gets FDA Fast-Track Designation
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
WPBF2h
Millions of doughnuts recalled over potential listeria contamination
Be cautious with your favorite pastries this week.
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous PolyposisUnderscores unmet need for a ...
manilatimes4h
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...
manilatimes5h
BRTX-100 Front and Center at ORS 2025
New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health” presentation - - Among other positive preliminary data analyses, ...
ImpediMed secures $15m in funding to support SOZO platform
ImpediMed has received $15m in funding for five years from SWK Holdings, which is set to enhance its ability to grow and ...